Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Vaccine consisting of 5 survivin peptides with different human leukocyte antigen restrictions

EU orphan designation number: EU/3/16/1791   
Active ingredient: Vaccine consisting of 5 survivin peptides with different human leukocyte antigen restrictions
Indication: Treatment of ovarian cancer
Sponsor: Dr Ulrich Granzer
Mauerkircherstraße 105, 81925 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/11/2016 Orphan designation EMA/OD/159/16 (2016)7635 of 18/11/2016